165 related articles for article (PubMed ID: 6817708)
1. Susceptibility of Neisseria meningitidis and Neisseria gonorrhoeae isolates to N-formimidoyl thienamycin.
Dudek EJ; Stephenson JD; Bohnhoff M; Lerner SA
Antimicrob Agents Chemother; 1982 Nov; 22(5):926-9. PubMed ID: 6817708
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
4. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
Horadam VW; Smilack JD; Montgomery CL; Werringloer J
Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing of fastidious organisms.
Andrews JM; Hadley N; Brenwald NP; Wise R
J Antimicrob Chemother; 1997 Mar; 39(3):436-7. PubMed ID: 9096199
[No Abstract] [Full Text] [Related]
8. In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin.
Witte JL; Sapico FL; Canawati HN
Antimicrob Agents Chemother; 1982 Nov; 22(5):906-8. PubMed ID: 6960806
[TBL] [Abstract][Full Text] [Related]
9. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
10. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
Cynamon MH; Palmer GS
Antimicrob Agents Chemother; 1982 Dec; 22(6):1079-81. PubMed ID: 6961887
[TBL] [Abstract][Full Text] [Related]
12. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
[TBL] [Abstract][Full Text] [Related]
14. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.
Kesado T; Hashizume T; Asahi Y
Antimicrob Agents Chemother; 1980 Jun; 17(6):912-7. PubMed ID: 6931548
[TBL] [Abstract][Full Text] [Related]
16. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
Barry AL; Jones RN; Thornsberry C; Ayers LW; Kundargi R
Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
[TBL] [Abstract][Full Text] [Related]
17. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
Tischhauser G; Kayser FH
Infection; 1983; 11(4):219-26. PubMed ID: 6578202
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
[TBL] [Abstract][Full Text] [Related]
19. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
20. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
